HIV-2 induces NF-κB activation and cyclooxygenase-2 expression in human astroglial cells

Virology

Volumn 380, Issue 1, 2008, Pages 144-151

  Álvarez, Susana ^a   Blanco, Almudena ^b   Kern, Florian ^b   Fresno, Manuel ^a   Muñoz Fernández, Ma Ángeles ^b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Cyclooxygenase; HIV 2; Human astrocytes; NF B

Indexed keywords

CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CYCLOOXYGENASE 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; SERINE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR RELA;

ARTICLE; ASTROCYTE; BINDING SITE; CELL ACTIVATION; CONTROLLED STUDY; ENZYME INDUCTION; FETUS; GENE DELETION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 2; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION;

ASTROCYTES; CELL LINE; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HIV-2; HUMANS; NF-KAPPA B; TRANSCRIPTION, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 52049114654     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.07.008     Document Type: Article

References (27)

1. Allport V.C., Slater D.M., Newton R., and Bennett P.R. NF-kappaB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol. Hum. Reprod. 6 6 (2000) 561-565
2. Alvarez S., Serramia M.J., Fresno M., and Munoz-Fernandez M. Human immunodeficiency virus type 1 envelope glycoprotein 120 induces cyclooxygenase-2 expression in neuroblastoma cells through a nuclear factor-kappaB and activating protein-1 mediated mechanism. J. Neurochem. 94 3 (2005) 850-861
3. Alvarez S., Serramia M.J., Fresno M., and Munoz-Fernandez M.A. HIV-1 envelope glycoprotein 120 induces cyclooxygenase-2 expression in astrocytoma cells through a nuclear factor-kappaB-dependent mechanism. Neuromol. Med. 9 2 (2007) 179-193
4. Anrather J., Csizmadia V., Soares M.P., and Winkler H. Regulation of NF-kappaB RelA phosphorylation and transcriptional activity by p21(ras) and protein kinase Czeta in primary endothelial cells. J. Biol. Chem. 274 19 (1999) 13594-13603
5. Brambilla R., Burnstock G., Bonazzi A., Ceruti S., Cattabeni F., and Abbracchio M.P. Cyclo-oxygenase-2 mediates P2Y receptor-induced reactive astrogliosis. Br. J. Pharmacol. 126 3 (1999) 563-567
6. Clapham P.R., and McKnight A. Cell surface receptors, virus entry and tropism of primate lentiviruses. J. Gen. Virol. 83 Pt 8 (2002) 1809-1829
7. Deng W.G., Zhu Y., and Wu K.K. Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-alpha-induced cyclooxygenase-2 promoter activation. J. Biol. Chem. 278 7 (2003) 4770-4777
8. Doerre S., and Corley R.B. Constitutive nuclear translocation of NF-kappa B in B cells in the absence of I kappa B degradation. J. Immunol. 163 1 (1999) 269-277
9. Endres M.J., Clapham P.R., Marsh M., Ahuja M., Turner J.D., McKnight A., Thomas J.F., Stoebenau-Haggarty B., Choe S., Vance P.J., Wells T.N., Power C.A., Sutterwala S.S., Doms R.W., Landau N.R., and Hoxie J.A. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87 4 (1996) 745-756
10. Eng L.F., and Ghirnikar R.S. GFAP and astrogliosis. Brain Pathol. 4 3 (1994) 229-237
11. Flora G., Pu H., Hennig B., and Toborek M. Cyclooxygenase-2 is involved in HIV-1 Tat-induced inflammatory responses in the brain. Neuromol. Med. 8 3 (2006) 337-352
12. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl (2002) S81-S96
13. Gonzalez-Scarano F., and Martin-Garcia J. The neuropathogenesis of AIDS. Nat. Rev., Immunol. 5 1 (2005) 69-81
14. Iniguez M.A., Martinez-Martinez S., Punzon C., Redondo J.M., and Fresno M. An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. J. Biol. Chem. 275 31 (2000) 23627-23635
15. Kohleisen B., Shumay E., Sutter G., Foerster R., Brack-Werner R., Nuesse M., and Erfle V. Stable expression of HIV-1 Nef induces changes in growth properties and activation state of human astrocytes. Aids 13 17 (1999) 2331-2341
16. Lucas S.B., Hounnou A., Peacock C., Beaumel A., Djomand G., N'Gbichi J.M., Yeboue K., Honde M., Diomande M., Giordano C., et al. The mortality and pathology of HIV infection in a west African city. Aids 7 12 (1993) 1569-1579
17. Martin A.G., and Fresno M. Tumor necrosis factor-alpha activation of NF-kappa B requires the phosphorylation of Ser-471 in the transactivation domain of c-Rel. J. Biol. Chem. 275 32 (2000) 24383-24391
18. Pasinetti G.M. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions. J. Neurosci. Res. 54 1 (1998) 1-6
19. Reeves J.D., and Doms R.W. Human immunodeficiency virus type 2. J. Gen. Virol. 83 Pt 6 (2002) 1253-1265
20. Schmitz M.L., Bacher S., and Kracht M. I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations. Trends Biochem. Sci. 26 3 (2001) 186-190
21. Schmitz M.L., and Baeuerle P.A. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. Embo J. 10 12 (1991) 3805-3817
22. Sharer L.R. Pathology of HIV-1 infection of the central nervous system. A review. J. Neuropathol. Exp. Neurol. 51 1 (1992) 3-11
23. Sizemore N., Leung S., and Stark G.R. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol. Cell. Biol. 19 7 (1999) 4798-4805
24. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69 (2000) 145-182
25. Vane J.R., Bakhle Y.S., and Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 97-120
26. Viatour P., Merville M.P., Bours V., and Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 30 1 (2005) 43-52
27. Willey S.J., Reeves J.D., Hudson R., Miyake K., Dejucq N., Schols D., De Clercq E., Bell J., McKnight A., and Clapham P.R. Identification of a subset of human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus strains able to exploit an alternative coreceptor on untransformed human brain and lymphoid cells. J. Virol. 77 11 (2003) 6138-6152